024850 — HLB Innovation Co Balance Sheet
0.000.00%
- KR₩205bn
- KR₩195bn
- KR₩31bn
Annual balance sheet for HLB Innovation Co, fiscal year end - March 31st, KRW millions except per share, conversion factor applied.
2019 March 31st | R2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,939 | 7,811 | 8,390 | 12,311 | 76,928 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,927 | 7,494 | 7,661 | 7,007 | 4,143 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 20,936 | 23,775 | 21,678 | 26,718 | 84,244 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 9,148 | 8,585 | 9,227 | 8,512 | 5,649 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 33,173 | 34,435 | 33,516 | 38,018 | 92,301 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,445 | 11,016 | 11,674 | 13,777 | 4,236 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 14,188 | 15,120 | 18,575 | 23,021 | 34,869 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 18,984 | 19,315 | 14,941 | 14,997 | 57,432 |
Total Liabilities & Shareholders' Equity | 33,173 | 34,435 | 33,516 | 38,018 | 92,301 |
Total Common Shares Outstanding |